These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11373889)

  • 1. [Hematologic aspects of inflammatory bowel diseases].
    Udvardy M; Altorjay I; Palatka K
    Orv Hetil; 2001 Apr; 142(17):883-6. PubMed ID: 11373889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
    Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
    Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: inherited thrombophilia in inflammatory bowel disease.
    Papa A; Danese S; Grillo A; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2003 Jun; 98(6):1247-51. PubMed ID: 12818264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
    Koutroubakis IE
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
    Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
    Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.
    Novacek G; Miehsler W; Kapiotis S; Katzenschlager R; Speiser W; Vogelsang H
    Am J Gastroenterol; 1999 Mar; 94(3):685-90. PubMed ID: 10086652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications.
    Twig G; Zandman-Goddard G; Szyper-Kravitz M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():166-73. PubMed ID: 16126956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coagulation system and inflammatory bowel disease: therapeutic and pathophysiologic implications].
    Folwaczny C
    Z Gastroenterol; 2002 Dec; 40(12):991-8. PubMed ID: 12518265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease.
    Saibeni S; Spina L; Vecchi M
    Eur Rev Med Pharmacol Sci; 2004; 8(5):205-8. PubMed ID: 15638231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coagulation changes in inflammatory intestinal disease].
    López Morante AJ; Prieto García M; Yuguero del Moral L; Sáez-Royuela F; Martín Lorente JL; Ojeda Giménez C
    Rev Clin Esp; 1992 Jan; 190(1):18-21. PubMed ID: 1546196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular complications associated with inflammatory bowel disease].
    Baños Madrid R; Salama Benarroch H; Martínez Crespo J; Morán Sánchez S; Vargas Acosta A; Mercader Martínez J
    An Med Interna; 2003 Feb; 20(2):81-4. PubMed ID: 12703161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thrombosis in inflammatory bowel disease.
    Srirajaskanthan R; Winter M; Muller AF
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):697-700. PubMed ID: 15947544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease.
    Heliö T; Wartiovaara U; Halme L; Turunen UM; Mikkola H; Palotie A; Färkkilä M; Kontula K
    Scand J Gastroenterol; 1999 Feb; 34(2):170-4. PubMed ID: 10192195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sleep disturbances in inflammatory bowel disease.
    Ranjbaran Z; Keefer L; Farhadi A; Stepanski E; Sedghi S; Keshavarzian A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1748-53. PubMed ID: 17914945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism.
    Tabibian JH; Roth BE
    J Clin Gastroenterol; 2009; 43(5):391-8. PubMed ID: 19247203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.